Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 703 (USA) (Dr. Okafor)
· consented 2013-02-20
Adverse events
4
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
moderate
assessed
2026-08-18
Moderate APPLICATION SITE IRRITATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-03-16 (study day 25.0); relationship: PROBABLE
severe
assessed
2026-08-18
Severe APPLICATION SITE IRRITATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-03-16 (study day 25.0); relationship: PROBABLE
moderate
assessed
2026-08-18
Moderate PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-05-04 (study day 74.0); relationship: PROBABLE
severe
assessed
2026-08-18
Severe PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-05-04 (study day 74.0); relationship: PROBABLE
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.